Optimizing Porphyrin-Based Drug Delivery: Insights into Lipophilicity and Membrane Interactions

Examine how lipophilicity, controlled by substituent chain length, affects porphyrin interactions with cell membranes and influences their accumulation in cancer cells for effective drug delivery.

PNC-27 Peptide: A Breakthrough in Targeting Cancer Cell Membranes

NINGBO INNO PHARMCHEM CO.,LTD. examines Peptide PNC-27, a molecule that targets cancer cell membranes through HDM-2 binding to induce cell death.

Advancing Cancer Treatment: The Science Behind Peptide PNC-27's Selective Cell Killing

NINGBO INNO PHARMCHEM CO.,LTD. explores the scientific basis of Peptide PNC-27, a molecule designed to target and destroy cancer cells via membrane lysis.

The Lipid Raft Connection: How Cholesterol Levels Impact Doxorubicin's Potency

Explore the critical role of lipid rafts and cellular cholesterol in determining the effectiveness of doxorubicin, a key area of research for NINGBO INNO PHARMCHEM CO.,LTD.

Synthetic Peptides in Oncology: The Case of PNC-27 and its Impact on Cancer Cell Membranes

Explore the cutting edge of oncology with synthetic peptides like PNC-27, focusing on its mechanism of action which involves targeting cancer cell membranes and inducing necrosis independently of p53.

PNC-27 Peptide: Revolutionizing Cancer Treatment Through Membrane Targeting

Learn about the cutting-edge PNC-27 peptide, its unique membrane-targeting strategy, and its impact on selective cancer cell necrosis, as explored in recent research.